CNS pipeline · person
Max Kates, MD
Clinical Advisor to Relmada Therapeutics. A clinician-scientist in bladder cancer, he is the R. Christian B. Evensen Professor of Urology at Johns Hopkins and Director of its Division of Urologic Oncology, has published more than 150 peer-reviewed manuscripts, and chairs the Phase 3 BRIDGE trial. He earned his MD from the Mount Sinai School of Medicine.
- 1 company
Current roles
- Relmada Therapeutics, Inc.Clinical Advisor · Advisor
Appears with
People sharing a company with Max.
- Charles Ence · Relmada Therapeutics, Inc.
- Charles J. Casamento · Relmada Therapeutics, Inc.
- Fabiana Fedeli · Relmada Therapeutics, Inc.
- John Glasspool · Relmada Therapeutics, Inc.
- Maged Shenouda · Relmada Therapeutics, Inc.
- Paul Kelly · Relmada Therapeutics, Inc.
- Raj S. Pruthi · Relmada Therapeutics, Inc.
- Sergio Traversa · Relmada Therapeutics, Inc.
- Yair Lotan · Relmada Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.